The once-daily pill, icotrokinra, was tested in patients with moderate-to-severe plaque psoriasis, a skin condition that ...
Hosted on MSN5h
J&J's skin disease drug meets main goals of late-stage studyThe drug, icotrokinra, was tested in patients with plaque psoriasis, a skin condition that causes dry and itchy patches on ...
In the ICONIC-LEAD study, once-daily icotrokinra showed significant skin clearance versus placebo in adults and adolescents with moderate to severe plaque psoriasis. At week 16, nearly two-thirds of ...
Psoriasis is an inflammatory disease, so it stands to reason that vitamin D may have something to do with either the development or course of the condition. Research shows that vitamin D levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback